MOTS-c 10mg

MOTS-c 10mg is for research purposes only. Search Hoyl2509020006 for COA.  

Automatic discounts will apply at check out: Buy 5 get 1 more for free, 10 gets 3 more for free, 15 gets 5 more, 20 gets 7. Place the total number you want in cart & the discounts will be automatic, This discount is combinable with free shipping, but not other discounts.

It is important to note that MOTS-c is an experimental peptide that has not been approved by the FDA for human use. Most research is limited to animal models or early clinical trials, and the long-term effects are unknown.

Commonly Reported Side Effects

• Injection site irritation, including redness, swelling, or bruising.

• Increased heart rate or heart palpitations.

• Insomnia.

• Fever.

• Mild fatigue or lethargy.

• Changes in hunger (some report appetite suppression, others report increased hunger).

• Rarely, muscle cramping.

• Very rarely, hypoglycemia (low blood sugar), especially when combined with fasting or other insulin-sensitizing substances.

• Potential for drug interactions, especially with medications that also target the AMPK pathway.

Other Potential Risks

• Contamination: Since it is an unregulated product, there is a risk of contamination with harmful substances, incorrect dosages, or impurities.

• Unknown long-term effects: There is no data available on what happens with long-term use of MOTS-c.

• Cancer risk: Because MOTS-c influences cellular growth pathways, there is a possible oncogenic effect, meaning it could potentially promote the growth of existing cancerous cells. It is not recommended for those with active cancers.

• Metabolic imbalances: It can affect cellular energy processes in potentially harmful ways, and can disrupt thyroid or cortisol rhythms in extremely high or prolonged usage.

• Immune reactions: The body may have an immune reaction to the substance.

• Athletic Bans: MOTS-c is banned by the World Anti-Doping Agency (WADA). It was added to the WADA Prohibited List in 2024 and is explicitly prohibited at all times under the category of Metabolic Modulators, specifically as an activator of the AMP-activated protein kinase (AMPK).